| Ghassan Fraij, MD | |
|
1847 E Southern Ave Ste 4, Tempe, AZ 85282-5881 | |
| (480) 878-4077 | |
| (480) 489-5269 |
| Full Name | Ghassan Fraij |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 18 Years |
| Location | 1847 E Southern Ave Ste 4, Tempe, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225253800 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Desert Medical Center | Mesa, AZ | Hospital |
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
| Entity Name | East Valley Cardiology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356334346 PECOS PAC ID: 8426034240 Enrollment ID: O20040624000696 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Entity Name | Abdul Memon Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760622344 PECOS PAC ID: 5294883211 Enrollment ID: O20090501000109 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Entity Name | District Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336472448 PECOS PAC ID: 7315086691 Enrollment ID: O20091125000583 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Entity Name | Valley Heart Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851694665 PECOS PAC ID: 8325228877 Enrollment ID: O20110215001130 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Entity Name | Cogent Healthcare Of Arizona Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568758266 PECOS PAC ID: 0648441006 Enrollment ID: O20110915000843 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Entity Name | Arizona Heart Doctor |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144569153 PECOS PAC ID: 5496992018 Enrollment ID: O20130518000048 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Entity Name | Arizona Cardiovascular Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780127266 PECOS PAC ID: 6507149085 Enrollment ID: O20170207001800 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Entity Name | Hospitalist Medicine Physicians Of Arizona - Phoenix, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649759754 PECOS PAC ID: 8123370087 Enrollment ID: O20181004001670 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Entity Name | Hospitalist Medicine Physicians Of Arizona - Phoenix Ii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659850766 PECOS PAC ID: 3072865757 Enrollment ID: O20181008001432 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Entity Name | Hospitalist Medicine Physicians Of Arizona - Goodyear, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790264802 PECOS PAC ID: 1951653187 Enrollment ID: O20181016002244 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Entity Name | Advanced Spine And Pain Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356950653 PECOS PAC ID: 0941610075 Enrollment ID: O20201102000020 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ghassan Fraij, MD Po Box 45200, Phoenix, AZ 85064-5200 Ph: (804) 878-4077 | Ghassan Fraij, MD 1847 E Southern Ave Ste 4, Tempe, AZ 85282-5881 Ph: (480) 878-4077 |
News Archive
Sanofi announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, which if approved would be administered as a single daily injection for the treatment of adults with type 2 diabetes.
It took almost 10 years for Elaine Fuchs, Ph.D., a Howard Hughes Medical Institute investigator at Rockefeller University, to find a postdoctoral fellow who shared her curiosity for the direction of cell divisions in the skin.
A new initiative in the battle against hospital infections caused by antibiotic-resistant superbugs will be led by the very doctor who first raised the alarm bells over the deadly germs.
Beyond Lucid Technologies, Inc., a healthcare IT startup serving the emergency medical, disaster management, and First Response industries, today announced the launch of its MediView software platform at the mHealth Summit, and the publication of a first-of-its-kind white paper surveying technologies currently available to connect ambulances with hospitals via telemedicine.
› Verified 8 days ago
Dr. Steven Alex Baldwin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1898 E Southern Ave, Tempe, AZ 85282 Phone: 480-838-0068 Fax: 480-838-3409 | |
Denise I Beighe, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 451 E University Dr, Tempe, AZ 85281 Phone: 480-965-3346 Fax: 480-965-8914 | |
Dr. M. Jamil Akhtar, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2157 E Baseline Rd, Suite 101, Tempe, AZ 85283 Phone: 480-962-9494 Fax: 480-962-8140 | |
Emil Slovak Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4600 S Mill Ave, Suite 280, Tempe, AZ 85282 Phone: 480-305-2888 Fax: 480-305-2889 | |
Supriya Bhandari, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 E Broadway Rd, Tempe, AZ 85282 Phone: 602-243-7277 Fax: 480-927-1092 | |
Dr. Monaliza Setudehnia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2055 E Southern Ave, Suite D, Tempe, AZ 85282 Phone: 480-345-7676 | |
Dr. Vanessa Joyce Tang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1920 E Baseline Rd, Tempe, AZ 85283 Phone: 480-453-5000 Fax: 480-345-5266 |